mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
7e-08 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |